Finance

Lists
JSPR:NASDAQ
Jasper Therapeutics Inc
$0.62
-2.57%
(-0.016) 1D
$0.57
-7.74% (-0.048)
Pre-market
Closed: Sep 18, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
$0.63
High
$0.65
Low
$0.60
Mkt. cap
20.69M
Avg. vol.
602.21K
Volume
0.00
52-wk high
$2.69
52-wk low
$0.32
EPS
-$1.58
Beta
3.04
Shares outstanding
33.28M
No. of employees
22
Open
$0.63
High
$0.65
Low
$0.60
Mkt. cap
20.69M
Avg. vol.
602.21K
Volume
0.00
52-wk high
$2.69
52-wk low
$0.32
EPS
-$1.58
Beta
3.04
Shares outstanding
33.28M
No. of employees
22
News stories
From web sources and news partners
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websitejaspertx.com
Analyst ratings
Based on 2 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current $0.62
$20.00 (+3,137.29%)
Average
$11.00 (+1,680.51%)
Lowest
$2.00 (+223.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$20.00
+3,137.3%
08/18/2026
Biren Amin
Piper Sandler
Buy
Initiated
$2.00
+223.7%
08/12/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
$3.00
+385.6%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
$1.50
+142.8%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$7.00
+1,033.1%
04/01/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+2,651.7%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.10M
10.85M
5.81M
5.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.26M
4.49M
5.14M
4.07M
Operating expense
17.36M
15.35M
10.95M
9.21M
Total operating expenses
17.36M
15.35M
10.95M
9.21M
Operating income
-17.36M
-15.35M
-10.95M
-9.21M
Other non operating income
88.00K
6.40M
9.61M
6.36M
EBT including unusual items
-18.74M
-9.10M
-1.17M
-2.76M
EBT excluding unusual items
-16.93M
-8.61M
-1.17M
-2.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18.74M
-9.10M
-1.17M
-2.76M
Net profit margin
-
-
-
-
Earnings per share
-1.25
-0.54
-0.38
-0.23
Interest and investment income
342.00K
338.00K
164.00K
82.00K
Interest expense
-
-
-
-
Net interest expenses
342.00K
338.00K
164.00K
82.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.13M
-15.06M
-10.93M
-9.19M
Gain or loss from assets sale
-2.00K
-
-
-80.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps